Video: Rigontec Details Immuno-oncology Strategy
Executive Summary
Rigontec CEO Christian Schetter describes tells how his company is tackling cancers and viral diseases with a novel RNA-based immuno-oncology strategy, in an interview at the recent Biotech Showcase.